RES
1r:r1
REP
REP1:6o(2+1)2d=-1--1
RES
2b:b-dglc-HEX-1:5
3s:n-acetyl
4b:a-lman-HEX-1:5|6:d
5b:a-lman-HEX-1:5|6:d
6b:a-lman-HEX-1:5|6:d
7b:a-dglc-HEX-1:5
LIN
1:2d(2+1)3n
2:2o(3+1)4d
3:4o(3+1)5d
4:5o(2+1)6d
5:4o(4+1)7d

• Theillet FX et al. Effects of backbone substitutions on the conformational behavior of Shigella flexneri O-antigens: implications for vaccine strategy. Glycobiology. 2011 Jan;21:(1):109-21. doi: 10.1093/glycob/cwq136. PMID: 21030536.

• Phalipon A et al. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection. J Immunol. 2009 Feb 15;182:(4):2241-7. doi: 10.4049/jimmunol.0803141. PMID: 19201878.

• Rynkiewicz MJ et al. Structural analysis of a protective epitope of the Francisella tularensis O-polysaccharide. Biochemistry. 2012 Jul 17;51:(28):5684-94. doi: 10.1021/bi201711m. PMID: 22747335.

• Vulliez-Le Normand B et al. Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody. Proc Natl Acad Sci U S A. 2008 Jul 22;105:(29):9976-81. doi: 10.1073/pnas.0801711105. PMID: 18621718.

• Theillet FX et al. Dynamic aspects of antibody:oligosaccharide complexes characterized by molecular dynamics simulations and saturation transfer difference nuclear magnetic resonance. Glycobiology. 2011 Dec;21:(12):1570-9. doi: 10.1093/glycob/cwr059. PMID: 21610193.

• Huan PT et al. Shigella flexneri type-specific antigen V: cloning, sequencing and characterization of the glucosyl transferase gene of temperate bacteriophage SfV. Gene. 1997 Aug 22;195:(2):207-16. doi: 10.1016/s0378-1119(97)00144-3. PMID: 9305766.

• Theillet FX et al. Structural mimicry of O-antigen by a peptide revealed in a complex with an antibody raised against Shigella flexneri serotype 2a. J Mol Biol. 2009 May 15;388:(4):839-50. doi: 10.1016/j.jmb.2009.03.057. PMID: 19328810.